Ultrastructural study of Rift Valley fever virus in the mouse model

Virology

Volumn 431, Issue 1-2, 2012, Pages 58-70

  Reed, Christopher ^a   Steele, Keith E ^a,b   Honko, Anna ^a   Shamblin, Joshua ^a   Hensley, Lisa E ^a,c   Smith, Darci R ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b MEDIMMUNE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Electron microscopy; Mouse model; Pathogenesis; Rift Valley fever; Ultrastructure; Viral hemorrhagic fever

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; FEMALE; LIVER CELL; LYMPHOCYTOSIS; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; STEM CELL; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; FEMALE; HEPATITIS; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; STEM CELLS; VIRUS REPLICATION;

ANIMALIA; RIFT VALLEY FEVER VIRUS;

EID: 84862332332     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.05.012     Document Type: Article

References (42)

1. Abdel-Wahab K.S., El Baz L.M., El-Tayeb E.M., Omar H., Ossman M.A., Yasin W. Rift Valley fever virus infections in Egypt: pathological and virological findings in man. Trans. R. Soc. Trop. Med. Hyg. 1978, 72:392-396.
2. Abu-Elyazeed R., el-Sharkawy S., Olson J., Botros B., Soliman A., Salib A., Cummings C., Arthur R. Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt. Bull. World Health Organ. 1996, 74:155-158.
3. Anderson G.W., Smith J.F. Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes. Virology 1987, 161:91-100.
4. Beniac D.R., Melito P.L., Devarennes S.L., Hiebert S.L., Rabb M.J., Lamboo L.L., Jones S.M., Booth T.F. The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy. PLoS One 2012, 7:e29608.
5. Bird B.H., Ksiazek T.G., Nichol S.T., Maclachlan N.J. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 2009, 234:883-893.
6. Bradfute S.B., Braun D.R., Shamblin J.D., Geisbert J.B., Paragas J., Garrison A., Hensley L.E., Geisbert T.W. Lymphocyte death in a mouse model of Ebola virus infection. J. Infect. Dis. 2007, 196(Suppl. 2):S296-S304.
7. Bradfute S.B., Swanson P.E., Smith M.A., Watanabe E., McDunn J.E., Hotchkiss R.S., Bavari S. Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis. J. Immunol. 2010, 184:327-335.
8. Capaldo C.T., Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta 2009, 1788:864-871.
9. Cheville N.F. Ultrastructural Pathology: The Comparative Cellular Basis of Disease 2009, Wiley-Blackwell, Amesterdam, IA. 2nd ed.
10. Daubney R., Hudson J., Garnham P. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J. Path. Bacteriol. 1931, 34:545-579.
11. De Maio A., Gingalewski C., Theodorakis N.G., Clemens M.G. Interruption of hepatic gap junctional communication in the rat during inflammation induced by bacterial lipopolysaccharide. Shock 2000, 14:53-59.
12. Ellis D.S., et al. Rift Valley fever virus: some ultrastructural observations on material from the outbreak in Egypt 1977. J. Gen. Virol. 1977, 42:8.
13. Ellis D.S., Shirodaria P.V., Fleming E., Simpson D.I. Morphology and development of Rift Valley fever virus in Vero cell cultures. J. Med. Virol. 1988, 24:161-174.
14. Geisbert T.W., Hensley L.E., Gibb T.R., Steele K.E., Jaax N.K., Jahrling P.B. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 2000, 80:171-186.
15. Geisbert T.W., Hensley L.E., Larsen T., Young H.A., Reed D.S., Geisbert J.B., Scott D.P., Kagan E., Jahrling P.B., Davis K.J. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 2003, 163:2347-2370.
16. Geisbert T.W., Jahrling P.B., Hanes M.A., Zack P.M. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J. Comp. Pathol. 1992, 106:137-152.
17. Gowen B.B., Hoopes J.D., Wong M.H., Jung K.H., Isakson K.C., Alexopoulou L., Flavell R.A., Sidwell R.W. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 2006, 177:6301-6307.
18. Gray K.K., et al. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Neg. Trop. Dis. 2012, 6.
19. Hensley L.E., Alves D.A., Geisbert J.B., Fritz E.A., Reed C., Larsen T., Geisbert T.W. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J. Infect. Dis. 2011, 204(Suppl. 3):S1021-S1031.
20. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002, 27:23-27.
21. Jaeschke H. Mechanisms of liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1083-1088.
22. Kamal S.A. Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol. J. 2009, 6:94.
23. Kolios G., Valatas V., Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 2006, 12:7413-7420.
24. Laughlin L.W., Meegan J.M., Strausbaugh L.J., Morens D.M., Watten R.H. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans. R. Soc. Trop. Med. Hyg. 1979, 73:630-633.
25. Lewis R.M., Cosgriff T.M., Peters C.J., Morrill J.C. Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells. J. Med. Virol. 1987, 23:207-215.
26. Madani T.A., Al-Mazrou Y.Y., Al-Jeffri M.H., Mishkhas A.A., Al-Rabeah A.M., Turkistani A.M., Al-Sayed M.O., Abodahish A.A., Khan A.S., Ksiazek T.G., Shobokshi O. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin. Infect. Dis. 2003, 37:1084-1092.
27. McGavran M.H., Easterday B.C. Rift Valley Fever virus hepatitis: light and electron microscopic studies in the mouse. Am. J. Pathol. 1963, 42:587-607.
28. McIntosh B.M., Russell D., dos Santos I., Gear J.H. Rift Valley fever in humans in South Africa. S. Afr. Med. J. 1980, 58:803-806.
29. Meegan J.M., Bailey, Charles L. Rift Valley fever. The Arboviruses, Epidemiology and Ecology 1989, 51-76. CRC Press, Boca Raton. T.P. Monath (Ed.).
30. Morrill J.C., Jennings G.B., Johnson A.J., Cosgriff T.M., Gibbs P.H., Peters C.J. Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch. Virol. 1990, 110:195-212.
31. Perkins E.M., McCaffery J.M. Conventional and immunoelectron microscopy of mitochondria. Methods Mol. Biol. 2007, 372:467-483.
32. Sidwell R.W., Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. 2003, 57:101-111.
33. Sitia G., Iannacone M., Aiolfi R., Isogawa M., van Rooijen N., Scozzesi C., Bianchi M.E., von Andrian U.H., Chisari F.V., Guidotti L.G. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 2011, 7:e1002061.
34. Smith D.R., Steele K.E., Shamblin J., Honko A., Johnson J., Reed C., Kennedy M., Chapman J.L., Hensley L.E. The pathogenesis of Rift Valley fever virus in the mouse model. Virology 2010, 407:256-267.
35. Srichaikul T., Nimmanitaya S., Artchararit N., Siriasawakul T., Sungpeuk P. Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 1977, 26:525-532.
36. Steele K.E., Anderson A.O., Mohamadzadeh M. Fibroblastic reticular cells and their role in viral hemorrhagic fevers. Expert Rev. Anti Infect. Ther. 2009, 7:423-435.
37. Struthers J.K., Swanepoel R. Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells. J. Gen. Virol. 1982, 60:381-384.
38. Swanepoel R., Blackburn N.K. Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells. J. Gen. Virol. 1977, 34:557-561.
39. Ursini-Siegel J., Zhang W., Altmeyer A., Hatada E.N., Do R.K., Yagita H., Chen-Kiang S. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. J. Immunol. 2002, 169:5505-5513.
40. Washburn J.O., Lyons E.H., Haas-Stapleton E.J., Volkman L.E. Multiple nucleocapsid packaging of Autographa californica nucleopolyhedrovirus accelerates the onset of systemic infection in Trichoplusia ni. J. Virol. 1999, 73:411-416.
41. Yadani F.Z., Kohl A., Prehaud C., Billecocq A., Bouloy M. The carboxy-terminal acidic domain of Rift Valley fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 1999, 73:5018-5025.
42. Yamamoto T., Kojima T., Murata M., Takano K., Go M., Chiba H., Sawada N. IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp. Cell Res. 2004, 299:427-441.